BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$231M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$145M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$63M |
| 4 |
Pinterest
PINS
|
+$53.4M |
| 5 |
Prologis
PLD
|
+$50.8M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$4.18B |
| 2 |
Apple
AAPL
|
+$1.93B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.78B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Microsoft
MSFT
|
+$1.2B |
Sector Composition
| 1 | Technology | 16.91% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Financials | 12.2% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Comtech Telecommunications
CMTL
$69.1M
| $198K | ﹤0.01% |
9,585
+3,270
| +52% | +$67.7K |
|
|
KRTX
2127
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $198K | ﹤0.01% |
1,949
-1,777
| -48% | -$181K |
|
2128
Cytokinetics
CYTK
$6.12B
| $198K | ﹤0.01% |
9,519
-7,325
| -43% | -$152K |
|
2129
Artivion
AORT
$1.92B
| $197K | ﹤0.01% |
8,357
-1,060
| -11% | -$25K |
|
|
TRHC
2130
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $197K | ﹤0.01% |
4,602
-1,210
| -21% | -$51.8K |
|
|
EBSB
2131
DELISTED
Meridian Bancorp, Inc.
EBSB
| $197K | ﹤0.01% |
13,198
+2,116
| +19% | +$31.6K |
|
|
TVRD
2132
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $196K | ﹤0.01% |
359
+93
| +35% | +$50.7K |
|
2133
Universal Electronics
UEIC
$62.3M
| $196K | ﹤0.01% |
3,728
-598
| -14% | -$31.4K |
|
2134
First Trust Cloud Computing ETF
SKYY
$3.2B
| $195K | ﹤0.01% |
2,053
-3,389
| -62% | -$322K |
|
|
SRNE
2135
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $195K | ﹤0.01% |
28,512
-94,136
| -77% | -$642K |
|
|
SAGE
2136
DELISTED
Sage Therapeutics
SAGE
| $195K | ﹤0.01% |
2,249
+1,218
| +118% | +$105K |
|
2137
Westlake Corp
WLK
$11.3B
| $194K | ﹤0.01% |
2,376
-2,181
| -48% | -$178K |
|
2138
WisdomTree
WT
$2.11B
| $194K | ﹤0.01% |
36,218
+1,869
| +5% | +$10K |
|
2139
Quince Therapeutics
QNCX
$85.9M
| $194K | ﹤0.01% |
6,973
+3,242
| +87% | +$90.1K |
|
2140
First Bancorp
FBNC
$2.29B
| $193K | ﹤0.01% |
5,719
-866
| -13% | -$29.3K |
|
|
GNMK
2141
DELISTED
GenMark Diagnostics, Inc
GNMK
| $193K | ﹤0.01% |
13,214
-2,893
| -18% | -$42.2K |
|
2142
Quanterix
QTRX
$224M
| $192K | ﹤0.01% |
4,135
-836
| -17% | -$38.9K |
|
2143
National Presto Industries
NPK
$802M
| $192K | ﹤0.01% |
2,173
+880
| +68% | +$77.8K |
|
2144
Stoneridge
SRI
$228M
| $192K | ﹤0.01% |
6,343
+143
| +2% | +$4.32K |
|
2145
AdvanSix
ASIX
$576M
| $191K | ﹤0.01% |
9,572
+2,447
| +34% | +$48.9K |
|
2146
Modine Manufacturing
MOD
$7.86B
| $191K | ﹤0.01% |
15,173
+2,957
| +24% | +$37.1K |
|
2147
Inogen
INGN
$231M
| $190K | ﹤0.01% |
4,262
-340
| -7% | -$15.2K |
|
2148
Opko Health
OPK
$1.11B
| $190K | ﹤0.01% |
48,059
-45,514
| -49% | -$180K |
|
2149
Unitil
UTL
$827M
| $189K | ﹤0.01% |
4,278
+806
| +23% | +$35.7K |
|
2150
Scotiabank
BNS
$78.7B
| $189K | ﹤0.01% |
3,500
| – | – |
|